2025-04-13 - Analysis Report
## Albemarle Corp (ALB) Stock Report

**0. Executive Summary:**

Albemarle Corp (ALB) is a leading global producer of lithium and other specialty chemicals.  Recent performance has significantly underperformed the S&P 500, showing signs of a possible turnaround based on recent price action but still faces significant challenges based on financial data.

**1. Performance Comparison:**

* **ALB Cumulative Return:** 1.84
* **VOO (S&P 500) Cumulative Return:** 66.36
* **Return Difference:** -64.52%

ALB has significantly underperformed the S&P 500 over the analyzed period.  The relative divergence of -64.5% places it at the 2nd percentile of its historical range against the S&P 500, indicating considerable underperformance.

**Albemarle Corp (ALB) Overview:** Albemarle Corporation is a global specialty chemicals company that produces and sells lithium, bromine, and other essential materials for various industries.

**Alpha and Beta Analysis:**

The provided data shows significant volatility in ALB's performance, with varying CAGR, Maximum Drawdown (MDD), Alpha, and Beta values across different periods.  High positive alpha values in some periods (2019-2021, 2020-2022) suggest outperformance, while negative alphas and high MDDs in other periods (2017-2019, 2022-2025) show significant underperformance and risk. The Beta generally fluctuates, showing varying levels of market sensitivity.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 99.0% | 7.7% | 70.0% | 0.0 | 13.7 |
| 2016-2018  | 13.0% | 58.1% | -5.0% | 0.0 | 8.4 |
| 2017-2019  | -45.0% | 58.1% | -74.0% | -0.0 | 8.1 |
| 2018-2020  | 101.0% | 62.9% | 75.0% | 0.7 | 16.6 |
| 2019-2021  | 268.0% | 62.9% | 214.0% | 0.8 | 26.5 |
| 2020-2022  | 239.0% | 75.8% | 233.0% | 1.1 | 24.8 |
| 2021-2023  | -53.0% | 77.6% | -69.0% | 0.6 | 16.6 |
| 2022-2024  | -204.0% | 77.6% | -221.0% | 0.8 | 10.1 |
| 2023-2025  | -346.0% | 77.6% | -360.0% | 2.1 | 6.7 |


**2. Recent Price Action:**

* **Closing Price:** $56.67
* **5-Day Moving Average:** $56.14
* **20-Day Moving Average:** $69.58
* **60-Day Moving Average:** $76.80

The closing price is below all three moving averages, suggesting a downward trend.  The recent price increase of 3.58% (from $54.71) might indicate a short-term bounce, but the overall trend remains bearish.

**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk)
* **RSI:** 26.96 (Oversold)
* **PPO:** -2.54 (Bearish)
* **20-Day Relative Divergence Change:** -2.9 (Short-term Downward Trend)
* **Expected Return:** 14402.2% (over 2 years vs. S&P 500) - This exceptionally high expected return needs further justification and context.  It seems unrealistic without additional supporting information.

The technical indicators point towards a bearish sentiment.  The RSI is in oversold territory, but this doesn't guarantee a price reversal. The MRI shows high risk. The significant price increase needs further investigation for underlying news or events causing the jump.

**4. Recent Earnings Analysis:**

| 날짜 | EPS | 매출 |
|---|---|---|
| 2024-11-06 | -9.45 | 1.35 B$ |
| 2024-07-31 | -1.96 | 1.43 B$ |
| 2024-05-01 | -0.08 | 1.36 B$ |
| 2023-11-01 | 2.58 | 2.31 B$ |
| 2024-11-06 | 2.58 | 2.31 B$ |

There is a discrepancy in the provided data (2 entries for 2024-11-06).  The most recent quarters show significant losses, suggesting a substantial downturn in profitability.  The large revenue drop from Q4 2023 to subsequent quarters needs clarification.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $1.23B | 11.22% |
| 2024-09-30 | $1.35B | -7.68% |
| 2024-06-30 | $1.43B | -0.74% |
| 2024-03-31 | $1.36B | 2.86% |
| 2023-12-31 | $2.36B | -29.88% |

Profit margins have been highly volatile and mostly negative in recent quarters, indicating significant financial challenges.  The sharp drop in revenue from Q4 2023 is concerning.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $9.96B | 0.76% |
| 2024-09-30 | $10.24B | -10.44% |
| 2024-06-30 | $11.22B | -1.68% |
| 2024-03-31 | $11.53B | 0.02% |
| 2023-12-31 | $9.41B | -6.56% |

ROE has been largely negative, reflecting the company's poor profitability. Equity fluctuates but shows a recent decline.


**6. Overall Analysis:**

ALB is currently experiencing significant financial headwinds, as evidenced by negative earnings, low and volatile profit margins, and negative ROE.  While the recent price increase is notable, it might be a temporary bounce in an overall bearish trend.  The high expected return claim requires further explanation and supporting data.  The company's substantial underperformance against the S&P 500 highlights the risk involved in investing in ALB.  Further investigation into the reasons behind the recent earnings decline and the potential for a turnaround is necessary before making any investment decisions.  The large discrepancies and inconsistencies within the provided data require clarification and verification from reliable financial sources.
